
Orphan drug developer Minoryx raises €51m
The Series C round was co-led by Columbus Venture Partners and Caixa Capital Risc, and supported by CDTI Innvierte, Fund+, Ysios Capital and other...

Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac
sAurobac Therapeutics SAS goal is to create next-generation antimicrobials and diagnostics to fight Antimicrobial Resistance (AMR). Decades ago,...

Study shows advantages of cellular agriculture
Replacing animal-source foods (ASFs) with novel or future foods (NFFs) – such as cultured milk, insect meal or mycoprotein – or plant-based...

AXA launches €440 m private equity healthcare strategy
The Strategy focuses specifically on companies in four core areas: medical devices, biopharmaceuticals, vaccines, and diagnostics. The...

TWB announces winners in industrial biotech start-up contest
Hosted for the fifth time by Toulouse White Biotechnology, the TWB Start-up Day showcased what industrial biotechnology can already do today to...

GSK acquires Sierra Oncology for 1.9bn
GSK is paying $1.9 bn in cash ($55 per share) for the deal. This is a 39 per cent premium to the Sierra share price on 12 April and a 63 per cent...

EU starts consultation on novel plant breeding methods
he EU Commission has launched its final consultation on the deregulation of new breeding techniques in agriculture. A study commissioned by the...